Association Between Use of Acid-Suppressive Drugs and Risk of Gastric Cancer
- 1 January 2008
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 31 (8), 675-684
- https://doi.org/10.2165/00002018-200831080-00004
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Application of lag‐time into exposure definitions to control for protopathic biasPharmacoepidemiology and Drug Safety, 2007
- Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UKGut, 2006
- Influence of Site Classification on Cancer Incidence Rates: An Analysis of Gastric Cardia CarcinomasJNCI Journal of the National Cancer Institute, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Does Acid Suppression by Antacids and H2 Receptor Antagonists Increase the Incidence of Atrophic Gastritis in Patients With or Without H. pylori Gastritis?Journal of Clinical Gastroenterology, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Risk of stomach cancer in patients with gastric or duodenal ulcerEuropean Journal Of Cancer Prevention, 1997
- The Risk of Stomach Cancer in Patients with Gastric or Duodenal Ulcer DiseaseNew England Journal of Medicine, 1996
- The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in QuébecJournal of Clinical Epidemiology, 1995
- The rising trend in oesophageal adenocarcinoma and gastric cardiaEuropean Journal Of Cancer Prevention, 1992